The European Commission is assuring domestic farmers of swift safeguard measures should the trade agreement cause market disruptions. This could allow France and other critics to give their approval to the deal.
Von Till Hoppe, Julia Dahm
In the espionage trial of his former aide Jian G., AfD politician Maximilian Krah admitted in court that his Brussels team had uncontrolled access to parliamentary data. Krah justified the practice by citing election campaign pressures and his trust in G., but conceded it was a rule violation.
Von Franziska Klemenz
A rare protest critical of the regime in western China left security forces embarrassed for nearly an hour. By the time the source of the messages was located, their initiator had long since left the country.
Von Marcel Grzanna
With a new diplomatic initiative, Xi Jinping is winning over the Global South. The concept is not yet fully developed, but its goal is clearly defined: a shift in international power relations.
Von Marcel Grzanna
At first glance, the arms display in Beijing looked like a repeat of 2015. But Xi’s speech was sharper, the guest list more narrowly defined. China’s role in the world has changed.
Von Jörn Petring
Kim Jong Un’s daughter Kim Ju-ae made her international debut in Beijing, appearing alongside her father at the military parade marking the 80th anniversary of the end of the war against Japan. The teenager was received by China’s top leaders, stepping for the first time onto the stage of global diplomacy. Her appearance is seen as a deliberate signal.
Von Jörn Petring
Foreign Minister Johann Wadephul promoted deeper economic cooperation in Indonesia in August – citing democratic ties as well. For Jakarta, however, autocracies remain attractive partners too.
Von Marcel Grzanna
The planned multibillion-dollar takeover of Ceconomy, parent company of MediaMarkt and Saturn, by Chinese online retailer JD.com has come under scrutiny by the German government. Berlin is reviewing potential risks to security and sovereignty.
Von Amelie Richter
Swiss pharmaceutical giant Novartis is expanding its partnership with Argo Biopharma, paying USD 160 million upfront for access to innovative cardiovascular therapies.
Von Amelie Richter
